Eden Research (LON:EDEN) Releases Quarterly Earnings Results

Eden Research (LON:EDEN) announced its quarterly earnings results on Wednesday. The company reported GBX (0.36) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Eden Research had a negative return on equity of 15.05% and a negative net margin of 44.31%.

Eden Research Stock Down 1.5%

Shares of EDEN traded down GBX 0.03 on Friday, hitting GBX 2.17. The company’s stock had a trading volume of 218,368 shares, compared to its average volume of 582,820. The company has a quick ratio of 2.42, a current ratio of 2.25 and a debt-to-equity ratio of 1.43. The firm’s fifty day moving average price is GBX 2.70 and its 200-day moving average price is GBX 3.14. Eden Research has a fifty-two week low of GBX 1.96 and a fifty-two week high of GBX 5. The firm has a market capitalization of £17.42 million, a price-to-earnings ratio of -4.89 and a beta of 1.57.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.